Thy1-CreERT2
品系全名
C57BL/6JSmo-Thy1em1(Kozak-CreERT2-WPRE-pA)Smoc
目录号
NM-KI-231054
品系状态
活体
基因信息
基因名
Thy1
品系描述
验证数据

Fig1. Detection of tdTomato expression on CD90+ cells in BM, spleen and blood.
In tamoxifen-treated HE/HE Thy1-CreERT2/R26-CAG-LSL-tdTomato mice, most CD90+ cells were tdTomato+ in bone marrow (~70 %), spleen (~90 %) and blood (~95 %).

Fig2. Detection of CD90 expression on tdTomato+ cells in BM, spleen and blood.
In HE/HE Thy1-CreERT2/R26-CAG-LSL-tdTomato mice, most tdTomato+ cells were CD90+ in bone marrow (~60 %), spleen (~90 %) and blood (66.5~89.4 %).
b
Fig3. CreERT2 mediated recombination in brain(Purkinje cell) of Thy1CreERT2/+;Rosa26 tdTomato/+ mice

Fig4. Detection of tdTomato(red) in various tissues of Thy1CreERT2/+;Rosa26 tdTomato/+ mouse.
Organs and tissues with tdTomato expression following tamoxifen induction include: brain, spinal cord, large intestine, small intestine, stomach, liver, heart, lungs, salivary glands, spleen, skin, pancreas, reproductive system, adrenal glands, kidneys, thymus, and eyeballs.
Tissues with expression leakage in the uninduced group include: brain, salivary glands, skin, reproductive system, and eyes (retina).(119-days old, female and male) (For more detailed information please contact our technical advisor.)
你也可能感兴趣
Tamoxifen诱导Cre-ERT2小鼠 使用指南
Cre-ERT2在无Tamoxifen诱导的情况下,在细胞质内处于无活性状态;当Tamoxifen诱导后,Tamoxifen的代谢产物4-OHT(雌激素类似物)与ERT结合,可使Cre-ERT2进核发挥Cre重组酶活性。
查看Cre-lox系统介绍及使用汇总
你一定听说过Cre-lox重组系统,无论你是否直接进行过基因操作。由于Cre-lox系统具有操作简单、重组率高的优点,如今已经成为体内外遗传操作的强有力工具。利用Cre-lox系统,可以在特定细胞、组织或整个生物体,甚至在特定时间点敲除或表达某个基因,实现对特定基因的时空特异性操作,这对基因功能的研究和人类疾病动物模型的建立都具有深刻影响。
查看
